An Outbreak of a New Infectious Disease COVID-19: β-coronaviruses as a Threat to Global Healthcare

by D. V. Gorenkov, L. M. Khantimirova, V. A. Shevtsov, A. V. Rukavishnikov, V. A. Merkulov, Yu. V. Olefir
Published 2020-03-01

Genome-Editing and Biomedical Cell Products: Current State, Safety and Efficacy

by A. A. Goryaev, M. V. Savkina, K. M. Mefed, V. P. Bondarev, V. A. Merkulov, V. V. Tarasov
Published 2018-09-01

Epidemiology of hepatitis A and vaccination policy

by I. N. Indikova, V. A. Shevtsov, A. R. Volgin, Yu. V. Olefir, V. A. Merkulov, V. P. Bondarev
Published 2018-02-01

RISK ASSESSMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS

by R. N. Alyautdin, B. K. Romanov, A. N. Yavorsky, N. D. Bunyatyan, V. A. Merkulov, A. N. Mironov
Published 2018-02-01

Common technological processes used in manufacture of biomedical cell culture products

by M. V. Supotnitskiy, A. A. Elapov, V. A. Merkulov, I. V. Borisevich, V. I. Klimov, A. N. Mironov
Published 2018-02-01

Promising methodological approaches to preclinical studies of biomedical cell-based products and their possible quality characteristics

by M. V. Supotnitskiy, A. A. Elapov, I. V. Borisevich, V. I. Klimov, E. V. Lebedinskaya, Mironov, V. A. Merkulov
Published 2018-02-01

Assessment of Residual Virulence of Francisella tularensis 15 NIIEG Vaccine Strain Based on Long-term Observations

by L. V. Sayapina, I. I. Khoreva, N. P. Baidalova, A. A. Goryaev, D. S. Davydov, V. P. Postupailo, V. A. Merkulov
Published 2018-04-01

Highly variable medicines - specific aspects of bioequivalence studies

by D. P. Romodanovsky, T. V. Eremenkova, M. A. Dranitsyna, D. V. Goryachev, R. R. Niyazov, E. V. Gavrishina, V. A. Merkulov
Published 2018-02-01

Justification of Methodological Approaches to Identification Testing of Biomedical Cell Products

by E. V. Melnikova, O. A. Rachinskaya, G. A. Trusov, M. D. Khorolsky, I. S. Semenova, N. V. Tereshkina, V. A. Merkulov
Published 2019-03-01

Direct and indirect methods of determining DNA nucleotide sequences in microorganisms

by R. A. Volkova, E. S. Skolotneva, E. V. Elbert, E. D. Mytsa, V. A. Merkulov, V. P. Bondarev, I. V. Borisevich
Published 2018-02-01

METHODOLOGICAL APPROACHES TO EXPERT EVALUATION OF PRECLINICAL AND CLINICAL TRIALS OF HUMAN IMMUNOGLOBULIN PRODUCTS

by V. B. Ivanov, V. D. Mosyagin, E. Yu. Kudasheva, Yu. V. Olefir, V. A. Merkulov, I. V. Borisevitch, V. P. Bondarev
Published 2017-10-01

Validation of the procedure for determination of amino acids composition of glatiramer acetate by C-13 NMR spectroscopy

by N. E. Kuz’Mina, S. V. Moiseev, V. I. Krylov, A. A. Kutin, E. A. Zhukov, V. A. Yashkir, V. A. Merkulov
Published 2018-02-01

Alipogene tiparvovec: a long journey of risk-benefit ratio assessment of gene therapy products

by R. N. Alyautdin, B. K. Romanov, A. P. Pereverzev, A. O. Chikalo, N. D. Bunyatyan, V. A. Merkulov, A. N. Mironov
Published 2018-02-01

The landmarks of control and licensing system development for medicinal products in Russia (25 years since the establishment of the first state institution for expert evaluation of...

by V. K. Lepakhin, Yu. V. Olefir, V. A. Merkulov, N. D. Bunyatyan, B. K. Romanov, A. N. Yavorsky, E. M. Rychihina
Published 2018-02-01

Modern biological/biotechnological medicinal products. Topical issues and prospects for development

by Yu. V. Olefir, N. V. Medunitsyn, Zh. I. Avdeeva, A. A. Soldatov, A. A. Movsesyants, V. A. Merkulov, V. P. Bondarev
Published 2018-02-01

Nanoscale Therapeutic System: Safety Assessment Features

by E. M. Bovina, B. K. Romanov, A. S. Kazakov, N. Yu. Velts, E. O. Zhuravleva, T. M. Bukatina, R. N. Alyautdin, V. A. Merkulov
Published 2019-09-01

Russian and International Regulatory Recommendations for the Development and Marketing Authorisation of COVID-19 Vaccines in the Context of the Pandemic

by A. A. Soldatov, Zh. I. Avdeeva, V. P. Bondarev, V. A. Merkulov, V. D. Mosyagin, V. B. Ivanov, D. V. Gorenkov, L. M. Khantimirova
Published 2020-12-01

Preparations of next generation monoclonal antibodies (issues and prospects)

by Zh. I. Avdeeva, A. A. Soldatov, N. A. Alpatova, N. V. Medunitsyn, V. P. Bondarev, A. N. Mironov, V. A. Merkulov, I. V. Sakaeva
Published 2018-02-01

First available biosimilar monoclonal antibodies

by Zh. I. Avdeeva, A. A. Soldatov, N. A. Alpatova, V. P. Bondarev, Yu. V. Olefir, V. A. Merkulov, V. D. Mosyagin, N. V. Medunitsyn
Published 2018-02-01

Using Real-Time RT-PCR Reagent Kits for Identity Testing of Measles, Mumps and Rubella Vaccines

by A. S. Binyatova, E. D. Mytsa, N. V. Chertova, R. A. Volkova, K. A. Sarkisyan, T. N. Ilyasova, T. N. Yunasova, A. A. Movsesyants, V. A. Merkulov
Published 2018-12-01